Access a unified, multi-phase testing platform that bridges high-throughput cell assays with advanced disease models to evaluate compound efficacy across every stage of vascular pathology and tissue resolution.
Creative Biolabs offers an integrated, custom-engineered suite of preclinical research services designed specifically to study the dynamic roles of macrophages in cardiovascular biology. We provide in-depth in vitro functional assays, real-time metabolic and autophagic flux tracking, and highly translatable in vivo models of plaque progression and regression. By partnering with us, our clients gain robust, high-resolution mechanistic data, clear validation of target engagement, and reproducible study endpoints that accelerate their early-stage drug discovery pipelines with absolute scientific confidence.
Atherosclerosis is a non-resolving inflammatory disease driven by the subendothelial retention of apolipoprotein B-containing lipoproteins. Macrophages serve as the central orchestrators of this pathology, balancing lipid handling, metabolic reprogramming, and tissue remodeling. Published scientific literature confirms that plaque stability depends on a dynamic balance of monocyte recruitment, local proliferation, autophagic recycling, and active emigration. Creative Biolabs’ macrophage platforms are designed to target these crucial molecular nodes, providing robust preclinical validation for next-generation vascular therapeutics.
Fig.1 Macrophage polarization in atherosclerotic plaques. 1
Access a unified, multi-phase testing platform that bridges high-throughput cell assays with advanced disease models to evaluate compound efficacy across every stage of vascular pathology and tissue resolution.
Select from diverse primary cell isolation options, including human PBMCs, monocyte-derived macrophages, primary vascular smooth muscle cells, or murine lineages, tailored to meet your precise target screening requirements.
Evaluate cell-to-cell signaling using specialized 3D vascular wall co-cultures, allowing your team to monitor pathological smooth muscle phenotypic transdifferentiation into macrophage-like cells under precise inflammatory stress.
Profile mitochondrial respiration and glycolytic activity in real time using Seahorse technology, confirming whether your candidate successfully reverses inflammatory metabolic shifts within targeted immune populations.
We quantify how macrophages internalize, process, and export modified lipids by analyzing key scavenger receptors, lipid endocytosis, and intracellular esterification processes while monitoring cholesterol efflux and autophagosome-mediated lipophagy for clearance.
Learn More →This platform evaluates plaque vulnerability by measuring NLRP3 inflammasome activation, pyroptosis, and cytokine release, alongside ER stress pathways and MMP-driven matrix degradation, to assess the functional impairment of critical vascular efferocytosis processes.
Learn More →This advanced co-culture model mimics arterial wall complexity, enabling real-time signaling analysis between endothelial cells, vascular smooth muscle cells, and macrophages to monitor pathological cell transdifferentiation under precise, inflammation-driven lipid stress conditions.
Learn More →Our scientific specialists bring decades of research history from top-tier academic and industrial environments, ensuring that your study is designed and executed with the highest level of vascular biology knowledge.
We utilize state-of-the-art laboratory systems to capture high-resolution cellular events, enabling our team to analyze complex subcellular transport, metabolic changes, and histopathological endpoints under strict operational controls.
All assay procedures are built upon rigorous, peer-reviewed methods that map directly to established scientific benchmarks, providing highly reproducible data that stands up to demanding peer reviews.
Our streamlined testing timelines and real-time data sharing pipelines provide your program with key results quickly, enabling your team to make fast, confident decisions on lead compound development.
Reach out to our experts to receive a highly detailed, customized preclinical research proposal tailored to your unique drug discovery goals, experimental timelines, and specific project requirements.
Can your assays differentiate between a compound that induces autophagy versus one that blocks autophagosome degradation?
Yes. We use tandem fluorescent reporter assays to monitor autophagic flux in real-time. By testing with lysosomal inhibitors, we definitively distinguish between induced autophagic clearance and blocked lysosomal degradation of autophagosomes.
What starting materials do we need to provide to initiate an in vivo plaque egress study?
Clients provide target compounds, reconstitution instructions, and a target product profile. Creative Biolabs handles the animal sourcing, diet formulation, cell labeling, surgical dosing protocols, and final histopathological analysis of the vascular tissues.
We analyze macrophage interactions with intracellular pathogens, assessing phagosomal maturation, antimicrobial peptide secretion, and inflammatory signaling pathways to evaluate candidate drug efficacy in controlling chronic infection-associated vascular and systemic immune responses.
Learn More →We investigate macrophage-driven fibrotic responses by quantifying myofibroblast activation, collagen deposition, and matrix metalloproteinase regulation to assess how therapeutic compounds modulate chronic tissue scarring and facilitate functional vascular tissue repair.
Learn More →Creative Biolabs delivers a highly translational, custom-engineered suite of services designed specifically to evaluate the complex role of macrophages in cardiovascular disease. We understand that standard, off-the-shelf assays fail to capture the high plasticity and donor-to-donor variability of primary immune cells. That is why our cardiovascular specialists work directly with your team to customize every stage of your project - from initial cell-sourcing parameters to tailored pathology endpoints.
Whether you need to discuss a specific molecular target, design a highly customized in vitro assay, or develop a sophisticated in vivo study protocol to map plaque regression, our team of cardiovascular experts is prepared to partner with you - contact us today.
Reference